Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02656420
Other study ID # IRB00006734
Secondary ID R01CA190610
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date January 2016
Est. completion date March 2016

Study information

Verified date April 2019
Source Johns Hopkins Bloomberg School of Public Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will examine the extent to which lower doses of a broccoli-derived beverage enhance the detoxication of air pollutants excreted in urine as compared to an maximal dose shown to be effective previously.


Description:

This is a 10-day placebo control Phase II broccoli sprout intervention to be conducted in Qidong, P.R. China. Up to twelve hundred people from the farming townships will be screened and one hundred seventy eligible individuals will be enrolled in the study. Participants will be randomized into 4 treatment groups: one will receive a juice beverage containing a standard dose of glucoraphanin- and sulforaphane-rich broccoli sprout powder mixed in pineapple juice, lime juice and water, the second will receive one-half dose, the third one-fifth dose and the fourth group will receive placebo beverage containing pineapple juice, lime juice and water. Participants will drink their assigned beverage every evening and provide consecutive 12-hour urine collections throughout the duration of the study.


Recruitment information / eligibility

Status Completed
Enrollment 170
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria:

- in good general health with no history of chronic illness

- normal liver function tests

- normal renal function tests

Exclusion Criteria:

- personal history of cancer except for non-melanoma skin cancer

- use of prescribed medicines

- for women, a positive pregnancy test

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Broccoli Sprout-derived Beverage
Maximum, half and one-fifth doses of broccoli sprout-derived beverage compared to placebos.
Placebos
Placebo as comparison to broccoli sprout-derived beverages

Locations

Country Name City State
China Qidong Liver Cancer Institute Qidong Jiangsu

Sponsors (3)

Lead Sponsor Collaborator
Johns Hopkins Bloomberg School of Public Health National Cancer Institute (NCI), Qidong Liver Cancer Institute

Country where clinical trial is conducted

China, 

References & Publications (1)

Egner PA, Chen JG, Zarth AT, Ng DK, Wang JB, Kensler KH, Jacobson LP, Muñoz A, Johnson JL, Groopman JD, Fahey JW, Talalay P, Zhu J, Chen TY, Qian GS, Carmella SG, Hecht SS, Kensler TW. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prev Res (Phila). 2014 Aug;7(8):813-823. doi: 10.1158/1940-6207.CAPR-14-0103. Epub 2014 Jun 9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sulforaphane Bioavailability Measured in Sequential 12-Hour Urine Samples Urinary excretion of broccoli-derived sulforaphane metabolites: sulforaphane-mercapturic acid. The metabolites were measured all 20 of the sequential 12-hour urine collections from each participant over the 10-day intervention period. Data from each individual were summed to provide a single "per 24-hours" value for each participant. 10 days
Secondary Modulation of Air Pollutant Excretion in Sequential Overnight 12-Hour Urine Samples Benzene-mercapturic acid (SPMA) excretion was measured in the sequential overnight 12-hour urine samples collected across the 10-day study period. Data from each individual were summed and averaged to provide a single "per 12-hours" value for each participant. 10 days
See also
  Status Clinical Trial Phase
Completed NCT01437501 - Broccoli Sprout Intervention in Qidong, P.R. China Phase 2